A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus

References

• Mobasseri M, Shirmohammadi M, Amiri T, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and Meta-analysis. Health Promot Perspect. 2020;10(2):98–115.
   PubMedGoogle Scholar
• Moini J. Epidemiology of diabetes. Amsterdam, Netherlands: Elsevier; 2019.
   Google Scholar
• Wagner D. Type 1 diabetes: pathogenesis, genetics and immunotherapy. Norderstedt, Germany: BoD– Books on Demand; 2011.
   Google Scholar
• Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:17016.
   PubMed Web of Science ®Google Scholar
• Powers AC. Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest. 2021;131(8):e142242.
   PubMedGoogle Scholar
• Roche EF, Menon A, Gill D, et al. Clinical presentation of type 1 diabetes. Pediatr Diabetes. 2005;6(2):75–78.
   PubMedGoogle Scholar
• Melendez-Ramirez LY, Yvonne Melendez-Ramirez L, Richards RJ, et al. Complications of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):625–640.
   PubMed Web of Science ®Google Scholar
• Papatheodorou K, Papanas N, Banach M, et al. Complications of diabetes 2016. J Diabet Res. 2016;2016:1–3.
   Google Scholar
• de Ferranti SD, de Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American heart association and American diabetes association. Diabetes Care. 2014;37(10):2843–2863.
   PubMedGoogle Scholar
• Ramchandani N, Heptulla RA. New technologies for diabetes: a review of the present and the future. Int J Pediatr Endocrinol. 2012;2012(1):28.
   PubMedGoogle Scholar
• Hanazaki K, Munekage M, Kitagawa H, et al. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. J Artif Organs. 2016;19:209–118.
   PubMed Web of Science ®Google Scholar
• Sasi AYB, Ben Sasi AY, Elmalki MA. A fuzzy controller for blood Glucose-Insulin system. J Signal Inform Proc. 2013;04(02):111–117.
   Google Scholar
• Luijf YM, Hans DeVries J, Zwinderman K, et al. Day and night Closed-Loop control in adults with type 1 diabetes. Diabetes Care. 2013;36(12):3882–3887.
   PubMed Web of Science ®Google Scholar
• Gonder-Frederick LA, Shepard JA, Grabman JH, et al. Psychology, technology, and diabetes management. Am Psychol. 2016;71(7):577–589.
   PubMedGoogle Scholar
• Solis-Herrera C, Triplitt C, Reasner C, et al. Classification of diabetes mellitus. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2018.
   Google Scholar
• Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019;15(11):635–650.
   PubMed Web of Science ®Google Scholar
• Alcántara-Aragón V. Improving patient self-care using diabetes technologies. Ther Adv Endocrinol Metab. 2019;10:2042018818824215.
   Google Scholar
• Shah R, Shah V, Patel M, et al. Insulin delivery methods: past, present and future. Int J Pharm Investig. 2016;6(1):1–9.
   PubMed Web of Science ®Google Scholar
• Singh R, Samuel C, Jacob JJ. A comparison of insulin pen devices and disposable plastic syringes - simplicity, safety, convenience and cost differences. Eur Endocrinol. 2018;14(1):47–51.
   PubMedGoogle Scholar
• Khan AM, Alswat KA. Benefits of using the i-Port system on Insulin-Treated patients. Diabetes Spectr. 2019;32(1):30–35.
   PubMedGoogle Scholar
• Kesavadev J, Saboo B, Krishna MB, et al. Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas. Diabetes Ther. 2020;11(6):1251–1269.
   PubMed Web of Science ®Google Scholar
• Teymourian H, Barfidokht A, Wang J. Electrochemical glucose sensors in diabetes management: an updated review (2010–2020). Chem Soc Rev. 2020;49(21):7671–7709.
   PubMed Web of Science ®Google Scholar
• Grosman B, Keenan DB, Mastrototaro JJ, et al. Nonlinear mapping technique for a physiological characteristic sensor. US Patent. 2018. p. 10001450. Available from: https://patentimages.storage.googleapis.com/d4/7d/02/2e7726de075baf/US10001450.pdf
   Google Scholar
• Bode BW. Clinical utility of the continuous glucose monitoring system. Diabet Technol Ther. 2000;2(1):35–41.
   Google Scholar
• Measuring glucose at the site of insulin delivery with a redox-mediated sensor. Biosens Bioelectron. 2020;165:112221.
   PubMedGoogle Scholar
• Signore MA, Rescio G, De Pascali C, et al. Fabrication and characterization of AlN-based flexible piezoelectric pressure sensor integrated into an implantable artificial pancreas. Sci Rep. 2019;9(1):1–11.
   PubMedGoogle Scholar
• Martinez CL, Oruklu E, Cinar A. Sensor fusion and distributed platform development for artificial pancreas. 2015 IEEE International Conference on Electro/Information Technology (EIT); 2015 May 21–23; Dekalb, IL, USA: IEEE; 2015. p. 592–597.
   Google Scholar
• Kavitha G, Senthil KK. Antenna as sensor to measure diabetes mellitus from pancreas in Non-Invasive method. 2019 1st International Conference on Innovations in Information and Communication Technology (ICIICT); 2019 Apr 25–26; Chennai, India: IEEE; 2019. p. 1–4.
   Google Scholar
• Bansod P, Shrivastava MC. Comparative study of current approaches for minimally invasive and non-invasive blood glucose monitoring. IETE Tech Rev. 2004;21(1):45–54.
   Web of Science ®Google Scholar
• Zanon M, Sparacino G, Facchinetti A, et al. Regularised model identification improves accuracy of multisensor systems for noninvasive continuous glucose monitoring in diabetes management. J Appl Math. 2013;2013:1–10.
   Google Scholar
• Lazaro Lazaro, Oruklu Sevil, Turksoy Cinar. Communication challenges in a multi-sensor closed-loop artificial pancreas system. 2016 IEEE Wireless Health (WH); 2016 Oct 25–27; Bethesda, MD, USA: IEEE; 2016. p. 1–5.
   Google Scholar
• Feng J, Turksoy K, Samadi S, Hajizadeh I, Cinar A. Hybrid online sensor error detection and functional redundancy for artificial pancreas control systems. IFAC-PapersOnLine. 2016;49(7):753–758.
   Google Scholar
• Kovatchev B. Automated closed-loop control of diabetes: the artificial pancreas. Bioelectron Med. 2018;4(1):14.
   PubMedGoogle Scholar
• Boughton CK, Hovorka R. Advances in artificial pancreas systems. Sci Transl Med. 2019;11(0):eaaw4949.
   PubMedGoogle Scholar
• Predictive infusion device operations and related methods and systems. 2021. [cited 6 May 2021]. Available from: https://patents.justia.com/patent/10960136
   Google Scholar
• Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371(4):313–325.
   PubMed Web of Science ®Google Scholar
• Graf A, McAuley SA, Sims C, et al. Moving toward a unified platform for insulin delivery and sensing of inputs relevant to an artificial pancreas. J Diabetes Sci Technol. 2017;11(2):308–314.
   PubMedGoogle Scholar
• Herrero P, Bondia J, Adewuyi O, et al. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability. Comput Methods Programs Biomed. 2017;146:125–131.
   PubMedGoogle Scholar
• Weaver KW, Hirsch IB. The hybrid Closed-Loop system: evolution and practical applications. Diabetes Technol Ther. 2018;20(S2):S216–S223.
   PubMedGoogle Scholar
• Pharmacologic Stress Testing Using Closed-Loop Drug Delivery. System theory and practical applications of biomedical signals. 2010.
   Google Scholar
• Glauser M. Closed-Loop flow control: towards practical applications (invited). 38th Fluid Dynamics Conference and Exhibit; 2008 Jun 23–26. Seattle, Washington; 2008.
   Google Scholar
• Thabit H, Hovorka R. Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia. 2016;59(9):1795–1805.
   PubMed Web of Science ®Google Scholar
• Strack TR. Exploring close-loop artificial pancreas use in type 1 diabetes. Drugs Fut. 2011;36(10):759.
   Google Scholar
• McAdams BH, Rizvi AA. An overview of insulin pumps and glucose sensors for the generalist. J Clin Med Res. 2016;5(1):5.
   Google Scholar
• Press M. Glucose sensors and insulin pumps: prospects for an artificial pancreas. In: Hakim N, editor. Artificial organs. Vol. 4, New techniques in surgery series. London: Springer; 2009. p. 77–91.
   Google Scholar
• Taleb N, Gingras V, Rabasa-Lhoret R. Insulin pumps and artificial pancreas. Encyclopedia of Endocrine Diseases. Elsevier; 2019. p. 245–258.
   Google Scholar
• Sora ND, Shashpal F, Bond EA, et al. Insulin pumps: review of technological advancement in diabetes management. Am J Med Sci. 2019;358(5):326–331.
   PubMed Web of Science ®Google Scholar
• Hermansen K. Insulin and new insulin analogues, insulin pumps and inhaled insulin in type 1 diabetes. Pharmacotherapy of Diabetes: New Developments. Springer; 2007. p. 41–51.
   Google Scholar
• Rodgers J. Insulin Pumps and Infusion Sets. Using insulin pumps in diabetes: a guide for nurses and other health professionals. John Wiley & Sons; 2008. p. 29–39.
   Google Scholar
• Dias CC, Kamath S, Vidyasagar S. Blood glucose regulation in diabetes mellitus patients: a review on mathematical plant model and control algorithms. Int J Bioinform Res Appl. 2018;14(1/2):90.
   Google Scholar
• Iancu E, Iancu I, Sfredel V. Predictive control of blood glucose in diabetes mellitus patients. 2010 IEEE International Conference on Automation, Quality and Testing, Robotics (AQTR), Vol. 2; 2010 May 28–30; Cluj-Napoca, Romania: IEEE; 2010. p. 1–6.
   Google Scholar
• Chakrabarty A, Zavitsanou S, Doyle FJ, et al. Event-Triggered model predictive control for embedded artificial pancreas systems. IEEE Trans Biomed Eng. 2018;65(3):575–586.
   PubMedGoogle Scholar
• Li C, Zhao C, Zhao H, et al. Blood glucose control based on rapid model identification with particle swarm optimization method. 2017 29th Chinese Control And Decision Conference (CCDC); 2017 May 28–30; Chongqing, China; 2017. p. 947–952.
   Google Scholar
• Hajizadeh I, Rashid M, Samadi S, et al. Adaptive and personalized plasma insulin concentration estimation for artificial pancreas systems. J Diabetes Sci Technol. 2018;12(3):639–649.
   PubMedGoogle Scholar
• Messori M, Toffanin C, Del Favero S, et al. Model individualization for artificial pancreas. Comput Methods Programs Biomed. 2019;171:133–140.
   PubMedGoogle Scholar
• Forlenza GP, Buckingham BA, Brown SA, et al. First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. Diabetes Technol Ther. 2021;23:410–424.
   PubMedGoogle Scholar
• Sabek OM, Farina M, Fraga DW, et al. Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment. J Tissue Eng. 2016;7:2041731416638198.
   Google Scholar
• Xu B, Fan D, Zhao Y, et al. Three-dimensional culture promotes the differentiation of human dental pulp mesenchymal stem cells into Insulin-Producing cells for improving the diabetes therapy. Front Pharmacol. 2019;10:1576.
   PubMed Web of Science ®Google Scholar
• Malek R, Davis SN. Novel methods of insulin replacement: the artificial pancreas and encapsulated islets. Rev Recent Clin Trials. 2016;11(2):106–123.
   PubMedGoogle Scholar
• Rouwkema J, Koopman BFJ, van Blitterswijk CA, et al. Supply of nutrients to cells in engineered tissues. Biotechnol Genetic Eng Rev. 26:163–178.
   PubMedGoogle Scholar
• Dulong J-L, Legallais C. Contributions of a finite element model for the geometric optimization of an implantable bioartificial pancreas. Artif Organs. 2002;26(7):583–589.
   PubMedGoogle Scholar
• Utech S, Boccaccini AR. A review of hydrogel-based composites for biomedical applications: enhancement of hydrogel properties by addition of rigid inorganic fillers. J Mater Sci. 2016;51(1):271–310.
   Web of Science ®Google Scholar
• Ghorpade VS. Preparation of hydrogels based on natural polymers via chemical reaction and cross-Linking. Hydrogels based on natural polymers. Amsterdam, Netherlands: Elsevier; 2020. p. 91–118.
   Google Scholar
• Yin R, He J, Bai M, et al. Engineering synthetic artificial pancreas using chitosan hydrogels integrated with glucose-responsive microspheres for insulin delivery. Mater Sci Eng C Mater Biol Appl. 2019;96:374–382.
   PubMedGoogle Scholar
• Razdan S, Sharma S. Internet of medical things (IoMT): overview, emerging technologies, and case studies. IETE Tech Rev. 2021;38(1):1–14.
   Web of Science ®Google Scholar
• Reddy N, Verma N, Dungan K, et al. Monitoring technologies- continuous glucose monitoring, mobile technology, biomarkers of glycemic control. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K editors. Endotext South. Dartmouth (MA): MDText.com, Inc.; 2020.
   Google Scholar
• Reddy M, Herrero P, Sharkawy ME, et al. Metabolic control with the bio-inspired artificial pancreas in adults with type 1 diabetes: a 24-Hour randomized controlled crossover study. J Diabetes Sci Technol. 2016;10(2):405–413.
   Google Scholar
• Colmegna P, Cengiz E, Garcia-Tirado J, et al. Impact of accelerating insulin on an artificial pancreas system without meal announcement: an in silico examination. J Diabetes Sci Technol. 2021;15(4):833–841.
   PubMedGoogle Scholar
• Quintal A, Messier V, Rabasa-Lhoret R, et al. A critical review and analysis of ethical issues associated with the artificial pancreas. Diabetes Metab. 2019;45(1):1–10.
   PubMedGoogle Scholar